Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Gains from Investment Securities (2016 - 2026)

Lexaria Bioscience's Gains from Investment Securities history spans 11 years, with the latest figure at $1.5 million for Q1 2026.

  • Quarterly results put Gains from Investment Securities at $1.5 million for Q1 2026, up 939.46% from a year ago — trailing twelve months through Feb 2026 was $1.5 million (up 939.46% YoY), and the annual figure for FY2025 was $586500.0, down 37.93%.
  • Gains from Investment Securities for Q1 2026 was $1.5 million at Lexaria Bioscience, up from $7331.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.5 million in Q1 2026 to a low of $7199.0 in Q3 2025.
  • The 5-year median for Gains from Investment Securities is $49600.0 (2023), against an average of $183120.9.
  • The sharpest move saw Gains from Investment Securities crashed 94.59% in 2024, then skyrocketed 939.46% in 2026.
  • Year by year, Gains from Investment Securities stood at $44600.0 in 2022, then skyrocketed by 90.58% to $85000.0 in 2023, then decreased by 3.53% to $82000.0 in 2024, then plummeted by 91.06% to $7331.0 in 2025, then surged by 20034.16% to $1.5 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $1.5 million, $7331.0, and $7199.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.